A genome-wide association study (GWAS) in Malaysia has reported a significant association of the GCKR rs1260326 with the development of hepatic steatosis, NAFLD, and nonalcoholic steatohepatitis (NASH) [31]. This evidence concerns the gene GCKR and metabolic dysfunction-associated steatotic liver disease.